BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6224124)

  • 1. [Value of moxalactam in the treatment of meningitis: efficacy and meningeal diffusion].
    Fosse T; Raoult D; David MF; Garnier JM; Arnolds M; Gallais H; Giraud F
    Pathol Biol (Paris); 1983 Jun; 31(6):477-9. PubMed ID: 6224124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)].
    Kobayashi Y; Haruta T; Kuroki S; Okura K; Fujiwara T; Morikawa Y
    Jpn J Antibiot; 1981 Apr; 34(4):587-98. PubMed ID: 6457167
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
    Ramos OM; Kaplan SL; Mason EO; Denson S; Pickering LK
    South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Presse Med; 1983 Jan; 12(3):139-42. PubMed ID: 6220351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of moxalactam for bacterial meningitis.
    Kaplan SL; Mason EO; Feigin RD
    J Pediatr; 1982 May; 100(5):843. PubMed ID: 6461736
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Olson DA; Hoeprich PD; Nolan SM; Goldstein E
    Ann Intern Med; 1981 Sep; 95(3):302-5. PubMed ID: 6455950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxalactam in treatment of recurrent Escherichia coli meningitis and ventriculitis in an infant with agammaglobulinemia.
    Kumar A; Aziz MT
    Drug Intell Clin Pharm; 1981 Jan; 15(1):50-1. PubMed ID: 6456138
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of moxalactam for gram-negative and Haemophilus influenzae meningitis: an appraisal.
    Dillon HC
    J Pediatr; 1981 Dec; 99(6):907-8. PubMed ID: 6458672
    [No Abstract]   [Full Text] [Related]  

  • 10. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ
    Rev Infect Dis; 1982; 4 Suppl():S606-9. PubMed ID: 6218572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis.
    Thirumoorthi MC; Buckley JA; Aravind MK; Kauffman RE; Dajani AS
    J Pediatr; 1981 Dec; 99(6):975-9. PubMed ID: 6458673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Barriere SL; Wilson CB; Pons VG
    Neurosurgery; 1982 Jun; 10(6 Pt 1):762-5. PubMed ID: 6213879
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy.
    McCracken GH; Schaad UB
    Rev Infect Dis; 1982; 4 Suppl():S603-5. PubMed ID: 6218571
    [No Abstract]   [Full Text] [Related]  

  • 14. [Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
    Bégué P; Safran C; Fleurette J; Brun Y; Floret D; Monnet P
    Sem Hop; 1983 Jun; 59(26):1972-6. PubMed ID: 6310789
    [No Abstract]   [Full Text] [Related]  

  • 15. New drugs for enteric gram-negative bacillary meningitis in adults.
    Med Lett Drugs Ther; 1981 Aug; 23(17):73-4. PubMed ID: 6267438
    [No Abstract]   [Full Text] [Related]  

  • 16. [The cerebrospinal fluid concentration of lamoxactam with reference to the therapy of gram-negative CNS infections].
    Nix WA; Hey O; Fabricius K
    Nervenarzt; 1982 Dec; 53(12):693-700. PubMed ID: 6218415
    [No Abstract]   [Full Text] [Related]  

  • 17. Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis.
    Modai J; Wolff M; Lebas J; Meulemans A; Manuel C
    Antimicrob Agents Chemother; 1982 Apr; 21(4):551-3. PubMed ID: 6211136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxalactam therapy for bacterial infections.
    Winston DJ; Busuttil RW; Kurtz TO; Young LS
    Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gram-negative bacillary meningitis. New therapy and changing concepts.
    Landesman SH; Cherubin CE; Corrado ML
    Arch Intern Med; 1982 May; 142(5):939-40. PubMed ID: 6211153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxalactam in pediatrics.
    Barson WJ; Nahata MC
    Drug Intell Clin Pharm; 1982 Feb; 16(2):113-4. PubMed ID: 6210520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.